Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression

PaperCitations, authors & open-access status

Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 93 citations, 2020 year and hybrid oa status.

93
Citations
2020
Year
hybrid
OA Status

Related on ScholarIQ

Yusuke Okuma
Author
Yuji Matsumoto
Author
Journal of Cancer Research and Clinical Oncology
Journal
Cancer Immunotherapy and Biomarkers
Topic
Cancer Immunotherapy and Biomarkers
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account